LBPO.CL01 · 临床研究 · Late-Breaking

Nutrigenomic stratification defines an HMGCS2-low, high-risk EO-CRC subset with a targetable stress-response vulnerability

海报缩略图:Nutrigenomic stratification defines an HMGCS2-low, high-risk EO-CRC subset with a targetable stress-response vulnerability
编号 LB002 展板 2 时间 4/19 02:00–05:00 区域 Section 50 主讲 Chia-Wei Cheng, PhD
分会场 Late-Breaking Research: Clinical Research 1
查看完整资料 下载 PDF 登录后可访问当前开放资料 AACR 官方页面 ↗

作者与单位

Chia-Wei Cheng1, Joel T. Gabre1, Han-Mo Chiu2, Lindsay LaFave3, Iok In Christine Chio1, Timothy C. Wang1

1Herbert Irving Comprehensive Cancer Ctr., New York, NY,2National Taiwan University Hospital, Taipei, Taiwan,3Albert Einstein College of Medicine, Bronx, NY

摘要 Abstract

Early-onset colorectal cancer (EO-CRC) is increasing worldwide and displays a remarkable distal (left-sided) predominance, yet the molecular features that stratify aggressive disease and link modifiable exposures to tumor biology remain incompletely defined. We surveyed for metabolic and microbiome-linked traits underlying the left-sided EO-CRC program using archived data from four patient cohorts (using AACR Project GENIE®) and biospecimens from trial-linked cohorts used for correlative molecular analyses (CUIMC IRB #AAAT8778; NTUH #202305003RINC). Our analyses revealed a high-risk EO-CRC patient subset (~30% of total EO-CRC) with low colonic HMGCS2 (EO:H_low) associated with inferior survival. Tumors from EO:H_low patients exhibit a microenvironment with metabolically stressed aberrant stem-cell (AbSC) state and increased representation of metastasis-linked cancer-associated fibroblasts (CAFs), the latter being independently associated with advanced-stage EO-CRC (III-IV). In Apc-driven CRC models, genetic ablation of HMGCS2 recapitulated the induction of AbSC and CAF, and accelerated distal-predominant tumorigenesis, whereas pharmacological inhibition of the stress-responsive pathway Rho/ROCK attenuated the phenotypes. Consistent with clinical risk associations, diet-induced obesity and dysbiosis further amplified the HMGCS2-Rho/ROCK axis and elicited host microbial-inflammatory responses that align with signatures observed in EO:H_low patients. Together, this study nominates an epithelial metabolic-stress axis that is amplified by environmental exposures underlying the distal predominance and aggressiveness of EO-CRC, highlighting a tractable vulnerability for intervention. This nutrigenomic framework is enabling an ongoing biomarker-guided correlative effort in trial-linked cohorts, benchmarking molecular readouts between study groups to inform mechanism-guided prevention and early interception.
利益披露 Disclosure
C. Cheng, None.. J. T. Gabre, None.. H. Chiu, None.. L. LaFave, None.. I. Chio, None.. T. C. Wang, None.

在会议检索中打开